161 related articles for article (PubMed ID: 30151273)
1. Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas.
Fareed MM; DeMora L; Esnaola NF; Denlinger CS; Karachristos A; Ross EE; Hoffman J; Meyer JE
J Gastrointest Oncol; 2018 Aug; 9(4):762-768. PubMed ID: 30151273
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
Dee EC; Freret ME; Horick N; Raldow AC; Goyal L; Zhu AX; Parikh AR; Ryan DP; Clark JW; Allen JN; Ferrone CR; Fernandez-Del Castillo C; Tanabe KK; Drapek LC; Hong TS; Qadan M; Wo JY
Ann Surg Oncol; 2020 Dec; 27(13):5161-5172. PubMed ID: 32740733
[TBL] [Abstract][Full Text] [Related]
3. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
4. Impact of Adjuvant Therapy on Survival in Curatively Resected Gallbladder Carcinoma.
Choudhary S; Asthana AK
J Clin Diagn Res; 2015 Sep; 9(9):XC01-XC04. PubMed ID: 26500994
[TBL] [Abstract][Full Text] [Related]
5. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
7. Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
Royce TJ; Liu Y; Milowsky MI; Efstathiou JA; Jani AB; Fischer-Valuck B; Patel SA
Clin Genitourin Cancer; 2021 Aug; 19(4):362-368. PubMed ID: 33839040
[TBL] [Abstract][Full Text] [Related]
8. Consolidation chemoradiation (cCTRT) improves survival in responders to first-line chemotherapy (CT) in locally advanced gallbladder cancer (LA-GBC): A new standard of care?
Alam MN; Agrawal S; Rastogi N; Maria Das KJ
Indian J Cancer; 2022; 59(4):577-583. PubMed ID: 36861528
[TBL] [Abstract][Full Text] [Related]
9. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.
Goel S; Aggarwal A; Iqbal A; Talwar V; Mitra S; Singh S
World J Gastroenterol; 2021 Dec; 27(45):7813-7830. PubMed ID: 34963744
[TBL] [Abstract][Full Text] [Related]
10. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Beckham TH; Barney C; Healy E; Wolfe AR; Branstetter A; Yaney A; Riaz N; McBride SM; Tsai CJ; Kang J; Yu Y; Chen L; Sherman E; Dunn L; Pfister DG; Tan J; Rupert R; Bonomi M; Zhang Z; Lobaugh SM; Grecula JC; Mitchell DL; Wobb JL; Miller ED; Blakaj DM; Diavolitsis VM; Lee N; Bhatt AD
Int J Cancer; 2020 Jul; 147(1):107-115. PubMed ID: 31609479
[TBL] [Abstract][Full Text] [Related]
11. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
13. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review.
Rodriguez RR; Abel S; Mamadgi J; Renz PB; Wegner RE; Raj MS
J Gastrointest Cancer; 2022 Sep; 53(3):700-708. PubMed ID: 34486086
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors.
Friedes C; Iocolano M; Lee SH; Li B; Duan L; Levin WP; Cengel KA; Sun LL; Aggarwal C; Marmarelis ME; Doucette A; Cohen RB; Xiao Y; Langer CJ; Bradley J; Feigenberg SJ; Yegya-Raman N
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1435-1444. PubMed ID: 37866762
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers.
Ma LX; Espin-Garcia O; Lim CH; Jiang DM; Sim HW; Natori A; Chan BA; Suzuki C; Chen EX; Liu G; Brar SS; Swallow CJ; Yeung JC; Darling GE; Wong RK; Kalimuthu SN; Conner J; Elimova E; Jang RW
J Gastrointest Oncol; 2020 Apr; 11(2):356-365. PubMed ID: 32399276
[TBL] [Abstract][Full Text] [Related]
18. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
19. A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.
Engineer R; Patkar S; Lewis SC; Sharma AD; Shetty N; Ostwal V; Ramaswamy A; Chopra S; Agrawal A; Patil P; Mehta S; Goel M
BMJ Open; 2019 Jun; 9(6):e028147. PubMed ID: 31253621
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
